Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | | | | 72 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | FAH CL E G H | 2184 | 3579 | OMIM:276700 | Tyrosinemia, type I | | | | 107 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | FTCD CL E G H | 10841 | 3974 | OMIM:229100 | Formiminotransferase deficiency | | | | 65 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 86 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | GCH1 CL E G H | 2643 | 4193 | OMIM:128230 | Dystonia, DOPA-responsive, with or without hyperphenylalaninemia | | | | 86 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | | | | 86 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | HPD CL E G H | 3242 | 5147 | ORPHA:2118 | Hawkinsinuria | | | | 23 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | HPD CL E G H | 3242 | 5147 | OMIM:140350 | HAWKINSINURIA | | | | 23 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | HPD CL E G H | 3242 | 5147 | OMIM:276710 | Tyrosinemia, type III | | | | 23 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 1 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | KYNU CL E G H | 8942 | 6469 | ORPHA:79155 | Hydroxykynureninuria | | | | 5 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 27 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | PAH CL E G H | 5053 | 8582 | ORPHA:79254 | Classic phenylketonuria | | | | 641 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | PCBD1 CL E G H | 5092 | 8646 | OMIM:264070 | Hyperphenylalaninemia, BH4-deficient, D | | | | 24 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | PCBD1 CL E G H | 5092 | 8646 | ORPHA:1578 | Pterin-4 alpha-carbinolamine dehydratase deficiency | | | | 24 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | | | | 92 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | | | | 19 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | QDPR CL E G H | 5860 | 9752 | OMIM:261630 | Hyperphenylalaninemia, bh4-deficient, C | | | | 43 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247598 | Neonatal intrahepatic cholestasis due to citrin deficiency | | | | 82 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | SPR CL E G H | 6697 | 11257 | OMIM:612716 | Dystonia, dopa-responsive, due to sepiapterin reductase deficiency | | | | 28 | | |
HP:0004338 | HP:0004338 | Abnormal circulating aromatic amino acid concentration | 0 | TAT CL E G H | 6898 | 11573 | OMIM:276600 | Tyrosine transaminase deficiency | | | | 43 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | | | | 72 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | FAH CL E G H | 2184 | 3579 | OMIM:276700 | Tyrosinemia, type I | | | | 107 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | FTCD CL E G H | 10841 | 3974 | OMIM:229100 | Formiminotransferase deficiency | | | | 65 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 86 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | GCH1 CL E G H | 2643 | 4193 | OMIM:128230 | Dystonia, DOPA-responsive, with or without hyperphenylalaninemia | | | | 86 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | | | | 86 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | HPD CL E G H | 3242 | 5147 | ORPHA:2118 | Hawkinsinuria | HP:0040281 - Very frequent | | | 23 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | HPD CL E G H | 3242 | 5147 | OMIM:140350 | HAWKINSINURIA | | | | 23 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | HPD CL E G H | 3242 | 5147 | OMIM:276710 | Tyrosinemia, type III | | | | 23 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 1 | | |
HP:0004338 | HP:0004365 | Abnormal circulating tryptophan concentration | 1 | KYNU CL E G H | 8942 | 6469 | ORPHA:79155 | Hydroxykynureninuria | HP:0040280 - Obligate | | | 5 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | | | | 27 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | PAH CL E G H | 5053 | 8582 | ORPHA:79254 | Classic phenylketonuria | | | | 641 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | PCBD1 CL E G H | 5092 | 8646 | OMIM:264070 | Hyperphenylalaninemia, BH4-deficient, D | | | | 24 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | PCBD1 CL E G H | 5092 | 8646 | ORPHA:1578 | Pterin-4 alpha-carbinolamine dehydratase deficiency | | | | 24 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | PNPO CL E G H | 55163 | 30260 | ORPHA:79096 | Pyridoxal phosphate-responsive seizures | HP:0040283 - Occasional | | | 92 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | | | | 19 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | QDPR CL E G H | 5860 | 9752 | OMIM:261630 | Hyperphenylalaninemia, bh4-deficient, C | | | | 43 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247598 | Neonatal intrahepatic cholestasis due to citrin deficiency | | | | 82 | | |
HP:0004338 | HP:0010893 | Abnormal circulating phenylalanine concentration | 1 | SPR CL E G H | 6697 | 11257 | OMIM:612716 | Dystonia, dopa-responsive, due to sepiapterin reductase deficiency | | | | 28 | | |
HP:0004338 | HP:0010917 | Abnormal circulating tyrosine concentration | 1 | TAT CL E G H | 6898 | 11573 | OMIM:276600 | Tyrosine transaminase deficiency | | | | 43 | | |
HP:0004338 | HP:0500141 | Hypophenylalaninemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0500135 | Hypotryptophanemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0500134 | Hypertryptophanemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0500133 | Hypotyrosinemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0100610 | Maternal hyperphenylalaninemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0004922 | Atypical hyperphenylalaninemia | 2 | CL E G H | | | | | | | | | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | BCS1L CL E G H | 617 | 1020 | OMIM:124000 | Mitochondrial complex III deficiency, nuclear type 1 | | | | 72 | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | FAH CL E G H | 2184 | 3579 | OMIM:276700 | Tyrosinemia, type I | . | | | 107 | | |
HP:0004338 | HP:0003612 | Positive ferric chloride test | 2 | FTCD CL E G H | 10841 | 3974 | OMIM:229100 | Formiminotransferase deficiency | . | | | 65 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | GCH1 CL E G H | 2643 | 4193 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 86 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | GCH1 CL E G H | 2643 | 4193 | OMIM:128230 | Dystonia, DOPA-responsive, with or without hyperphenylalaninemia | . | | | 86 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | GCH1 CL E G H | 2643 | 4193 | OMIM:233910 | Hyperphenylalaninemia, BH4-deficient, B | . | | | 86 | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | HPD CL E G H | 3242 | 5147 | OMIM:140350 | HAWKINSINURIA | . | | | 23 | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | HPD CL E G H | 3242 | 5147 | OMIM:276710 | Tyrosinemia, type III | . | | | 23 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | IMPDH2 CL E G H | 3615 | 6053 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 1 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | NR4A2 CL E G H | 4929 | 7981 | ORPHA:98808 | Autosomal dominant dopa-responsive dystonia | HP:0040282 - Frequent | | | 27 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | PAH CL E G H | 5053 | 8582 | ORPHA:79254 | Classic phenylketonuria | HP:0040281 - Very frequent | | | 641 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | PCBD1 CL E G H | 5092 | 8646 | OMIM:264070 | Hyperphenylalaninemia, BH4-deficient, D | | | | 24 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | PCBD1 CL E G H | 5092 | 8646 | OMIM:264070 | Hyperphenylalaninemia, BH4-deficient, D | | | | 24 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | PCBD1 CL E G H | 5092 | 8646 | ORPHA:1578 | Pterin-4 alpha-carbinolamine dehydratase deficiency | HP:0040281 - Very frequent | | | 24 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | PTS CL E G H | 5805 | 9689 | OMIM:261640 | Hyperphenylalaninemia, BH4-deficient, A | . | | | 19 | | |
HP:0004338 | HP:0004923 | Hyperphenylalaninemia | 2 | QDPR CL E G H | 5860 | 9752 | OMIM:261630 | Hyperphenylalaninemia, bh4-deficient, C | . | | | 43 | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | SLC25A13 CL E G H | 10165 | 10983 | ORPHA:247598 | Neonatal intrahepatic cholestasis due to citrin deficiency | HP:0040282 - Frequent | | | 82 | | |
HP:0004338 | HP:0008297 | Transient hyperphenylalaninemia | 2 | SPR CL E G H | 6697 | 11257 | OMIM:612716 | Dystonia, dopa-responsive, due to sepiapterin reductase deficiency | . | | | 28 | | |
HP:0004338 | HP:0003231 | Hypertyrosinemia | 2 | TAT CL E G H | 6898 | 11573 | OMIM:276600 | Tyrosine transaminase deficiency | . | | | 43 | | |